Christopher Nortcliffe

Christopher Nortcliffe is an experienced professional in mass spectrometry and biopharmaceuticals, currently serving as the Mass Spectrometry Manager at Sterling Pharma Solutions since September 2021, where expertise in high-resolution mass spectrometry aids in the discovery and development of ADCs. Prior to this role, Christopher worked as an Applications Specialist in LC/MS Biologics at SCIEX, focusing on biopharmaceutical applications. Christopher completed a PhD in Biophysical Chemistry at The University of Manchester, with research on non-covalent interactions utilizing mass spectrometry. Additional experience includes research positions at the University of Edinburgh and Edinburgh Cancer Research, alongside a strong educational foundation in chemistry and proteomics.